Skip to main content

Cloning-Free (DNA-Free) CRISPR-Cas9-Mediated Gene Editing in Human Liver Cell Line and Its Detection

  • Protocol
  • First Online:
CRISPR-Cas Methods

Part of the book series: Springer Protocols Handbooks ((SPH))

  • 1455 Accesses

Abstract

The clustered regularly interspaced short palindromic repeats-CRISPR-associated protein 9 (CRISPR-Cas9) system is a powerful tool for precise genome editing. The recent efforts of scientists allow to improve current genome engineering techniques, which are used to generate modified cell lines for functional studies. Here we describe, in detail, the protocol for DNA-free CRISPR-Cas9-mediated gene editing in a human liver cell line. Briefly, we used lipofection to deliver a ribonucleoprotein (RNP) complex consisting of Cas9 protein, crRNA, and tracrRNA to the cells. The crRNA quality was validated before transfection by performing an in vitro cleavage assay and visualized using an agarose gel. Afterward, we checked the efficiency of the target gene modification by Sanger sequencing and T7 endonuclease I digestion. Our goal is to provide a simple protocol for CRISPR-Cas9-mediated gene modification.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Rohn TT, Kim N, Isho NF, Mack JM (2018) The potential of CRISPR/Cas9 gene editing as a treatment strategy for Alzheimer’s Disease. J Alzheimers Dis Parkinsonism 8:439. https://doi.org/10.4172/2161-0460.1000439

    Article  PubMed  PubMed Central  Google Scholar 

  2. Kolli N, Lu M, Maiti P, Rossignol J, Dunbar GL (2018) Application of the gene editing tool, CRISPR-Cas9, for treating neurodegenerative diseases. Neurochem Int 112:187–196. https://doi.org/10.1016/j.neuint.2017.07.007

    Article  CAS  PubMed  Google Scholar 

  3. Wong TWY, Cohn RD (2017) Therapeutic applications of CRISPR/Cas for Duchenne muscular dystrophy. Curr Gene Ther 17(4):301–308. https://doi.org/10.2174/1566523217666171121165046

    Article  CAS  PubMed  Google Scholar 

  4. Zhang F, Wen Y, Guo X (2014) CRISPR/Cas9 for genome editing: progress, implications and challenges. Hum Mol Genet 23(R1):R40–R46. https://doi.org/10.1093/hmg/ddu125

    Article  CAS  PubMed  Google Scholar 

  5. Hsu PD, Lander ES, Zhang F (2014) Development and applications of CRISPR-Cas9 for genome engineering. Cell 157(6):1262–1278. https://doi.org/10.1016/j.cell.2014.05.010

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Mali P, Yang L, Esvelt KM et al (2013) RNA-guided human genome engineering via Cas9. Science 339(6121):823–826. https://doi.org/10.1126/science.1232033

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Sander JD, Joung JK (2014) CRISPR-Cas Systems for editing, regulating and targeting genomes. Nat Biotechnol 32(4):347–355. https://doi.org/10.1038/nbt.2842

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Kouranova E, Forbes K, Zhao G et al (2016) CRISPRs for optimal targeting: delivery of CRISPR components as DNA, RNA, and protein into cultured cells and single-cell embryos. Hum Gene Ther 27(6):464–475. https://doi.org/10.1089/hum.2016.009

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Liang X, Potter J, Kumar S et al (2015) Rapid and highly efficient mammalian cell engineering via Cas9 protein transfection. J Biotechnol 208:44–53. https://doi.org/10.1016/j.jbiotec.2015.04.024

    Article  CAS  PubMed  Google Scholar 

  10. Shao LW, Niu R, Liu Y (2016) Neuropeptide signals cell non-autonomous mitochondrial unfolded protein response. Cell Res 26(11):1182–1196. https://doi.org/10.1038/cr.2016.118

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Desktop Genetics. https://www.deskgen.com/landing/cloud. Accessed January 9, 2019

  12. Image LabTM Software—Life Science Research by Bio-Rad. http://www.bio-rad.com/en-pl/product/image-lab-software?ID=KRE6P5E8Z. Accessed January 9, 2019

  13. ImageJ. https://imagej.nih.gov/ij/. Accessed January 9, 2019

  14. Sunset Notice—GeneSifter Lab Edition. http://informatics.perkinelmer.com/Support/SupportNews/details/?SupportNews=124. Accessed January 9, 2019

  15. Sentmanat MF, Peters ST, Florian CP et al (2018) A survey of validation strategies for CRISPR-Cas9 editing. Sci Rep 8(1)

    Google Scholar 

Download references

Acknowledgment

This study was financially supported by the National Science Centre, Poland (grant no. 2017/25/N/NZ5/01885; 2017/25/B/NZ5/02762).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hiroaki Taniguchi .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Śmiech, M., Leszczyński, P., Haque, E., Taniguchi, H. (2020). Cloning-Free (DNA-Free) CRISPR-Cas9-Mediated Gene Editing in Human Liver Cell Line and Its Detection. In: Islam, M.T., Bhowmik, P.K., Molla, K.A. (eds) CRISPR-Cas Methods . Springer Protocols Handbooks. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0616-2_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-0616-2_10

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-0615-5

  • Online ISBN: 978-1-0716-0616-2

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics